BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24438019)

  • 21. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
    Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
    Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cancer stem cell markers in breast phyllodes tumor.
    Kim SI; Koo JS
    Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.
    Tsang JY; Mendoza P; Lam CC; Yu AM; Putti TC; Karim RZ; Scolyer RA; Lee CS; Tan PH; Tse GM
    Histopathology; 2012 Oct; 61(4):667-74. PubMed ID: 22571452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.
    Karim RZ; Gerega SK; Yang YH; Spillane A; Carmalt H; Scolyer RA; Lee CS
    Histopathology; 2010 Jun; 56(7):868-75. PubMed ID: 20497245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of succinate dehydrogenase in breast phyllodes tumor.
    Choi J; Kim DH; Jung W; Koo JS
    Histol Histopathol; 2014 Oct; 29(10):1343-54. PubMed ID: 24807638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
    Kim HM; Lee YK; Koo JS
    Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
    [No Abstract]   [Full Text] [Related]  

  • 27. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
    Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
    Kuijper A; van der Groep P; van der Wall E; van Diest PJ
    Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
    Ibrahim WS
    Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
    Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
    Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of serine and glycine-related enzymes in phyllodes tumor.
    Kwon JE; Kim DH; Jung WH; Koo JS
    Neoplasma; 2014; 61(5):566-78. PubMed ID: 25030440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
    Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
    Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.